Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M542Revenue $M4.1Net Margin (%)-2,636.9Altman Z-Score7.7
Enterprise Value $M346EPS $-3.4Operating Margin %-2,594.4Piotroski F-Score3
P/E(ttm)--Beneish M-Score0.2Pre-tax Margin (%)-2,636.9Higher ROA y-yN
Price/Book2.910-y EBITDA Growth Rate %-14.1Quick Ratio7.0Cash flow > EarningsY
Price/Sales1085-y EBITDA Growth Rate %-8.5Current Ratio7.0Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-65.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-82.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M38.5ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with DVAX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DVAXJohn Paulson 2015-12-31 Buy 0.02%$22.08 - $27.9
($25.09)
$ 14.09-44%New holding133,800
DVAXGeorge Soros 2012-06-30 Sold Out -0.03%$35.2 - $52.6
($42.79)
$ 14.09-67%Sold Out0
DVAXGeorge Soros 2012-03-31 Reduce-0.09%$32.8 - $50.3
($40.26)
$ 14.09-65%Reduce -62.50%37,500
DVAXGeorge Soros 2011-12-31 Buy 0.14%$18.2 - $33.3
($28.25)
$ 14.09-50%New holding100,000
DVAXGeorge Soros 2011-09-30 Sold Out -0.0026%$18.4 - $31.6
($24.39)
$ 14.09-42%Sold Out0
DVAXGeorge Soros 2011-06-30 Buy 0.0026%$24.6 - $28.1
($26.4)
$ 14.09-47%New holding6,610
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DVAX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


DVAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Janssen RobertVice President 2015-10-08Buy100$23.34-39.63view
Gray EddieCEO and Director 2014-08-14Buy2,500$14.9-5.44view
KISNER DANIEL LDirector 2013-10-30Buy1,000$10.830.46view
ORONSKY ARNOLD LDirector 2013-10-30Buy18,605$10.830.46view
Phillips Peggy VDirector 2013-10-30Buy9,302$10.830.46view
Janssen RobertChief Medical Officer and VP 2013-07-09Sell0$030.46view
Novack David FSenior Vice President 2013-03-25Sell0$030.46view
COFFMAN ROBERTChief Scientific Officer & VP 2012-11-06Sell800$43.1-67.31view
KESSEL MARKDirector 2012-10-16Sell600,000$47.3-70.21view
COFFMAN ROBERTChief Scientific Officer & VP 2012-10-05Sell800$49.4-71.48view

Press Releases about DVAX :

Quarterly/Annual Reports about DVAX:

News about DVAX:

Articles On GuruFocus.com
William Blair’s Top BioPharmaceutical Stock Picks for Q1 2015 Dec 23 2014 
Two Promising Health Care Stocks with Market Capitalizations Under $500 Million Jun 11 2014 
Top Three Largest Insider Buys of the Past Week Nov 05 2013 
Steven Cohen, George Soros, John Paulson All Add to Holdings Mar 07 2012 
Dynavax Technologies Corp. Reports Operating Results (10-Q) Aug 02 2010 
Dynavax Technologies Corp. Reports Operating Results (10-Q) May 10 2010 
Price % Loser Stocks of The Day: SIGA Technologies Inc., Universal Travel Group, U.S. Concrete Inc., Dec 10 2009 
Dynavax Technologies Corp. Reports Operating Results (10-Q) Oct 30 2009 
Dynavax Technologies Corp. Reports Operating Results (10-Q) Aug 06 2009 
Dynavax Technologies Corp. Reports Operating Results (10-Q) Apr 30 2009 

More From Other Websites
ETF’s with exposure to Dynavax Technologies Corp. : April 29, 2016 Apr 29 2016
Dynavax Technologies Corp. breached its 50 day moving average in a Bearish Manner : DVAX-US : April... Apr 28 2016
Dynavax downgraded by RBC Capital Mkts Apr 28 2016
DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 27 2016
Why Traders Are Selling These Five Tanking Stocks? Apr 27 2016
Dynavax Receives Notification of PDUFA Extension for HEPLISAV-B to December 15, 2016 Apr 27 2016
Dynavax Receives Notification of PDUFA Extension for HEPLISAV-B to December 15, 2016 Apr 27 2016
DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other... Apr 19 2016
Dynavax Presents Encouraging Data From Clinical Trial of Immuno-Oncology Product Candidate, SD-101 Apr 18 2016
Dynavax Presents Pivotal Phase 3 Data Showing HEPLISAV-B(TM) Provides Significantly Higher... Apr 18 2016
Dynavax Presents Pivotal Phase 3 Data Showing HEPLISAV-B(TM) Provides Significantly Higher... Apr 18 2016
Dynavax Presents Encouraging Data From Clinical Trial of Immuno-Oncology Product Candidate, SD-101 Apr 18 2016
Dynavax Technologies Corp. – Value Analysis (NASDAQ:DVAX) : April 5, 2016 Apr 05 2016
Dynavax Technologies Corp. breached its 50 day moving average in a Bullish Manner : DVAX-US : April... Apr 04 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)